OLMA
NASDAQ · Biotechnology
Olema Pharmaceuticals Inc
$12.05
+0.25 (+2.12%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+39.5% upside
Low Target
$15.48
Average Target
$16.81
High Target
$21.94
Current Price
$12.05
Current
$12.05
$12.05
Target
$16.81
$16.81
$15.48
$16.81 avg
$21.94
Scenario Analysis
Bear Case
$15.48
28.5%
Low target
Base Case
$16.81
+39.5%
Avg target
Bull Case
$21.94
+82.1%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$36.26
-66.8% from high
52-Week Low
$4.47
+169.6% from low
Target vs 52W High
$16.81
-53.6% vs high
Next Earnings Report
Aug 11, 2026
1d
tomorrow
EPS Est: $-0.56
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |